Survodutide

DB18989InvestigationalProtein Based Therapies

Survodutide is under investigation in clinical trial NCT06077864 (A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)).

Mechanism: Pharmacologically active on Glucagon receptor and Glucagon-like peptide 1 receptor
Curator reviewed
Code names: BI4-56906

Resolves to

Compound

UNII2ALA66NS64CAS2805997-46-8

Targets

P47871GCGRP43220GLP1R

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

20Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Survodutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account